Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study

Anti-COVID-19 vaccination may have functional implications for immune checkpoint inhibitor treatment in patients with cancer. This study was undertaken to determine whether the safety or efficacy of anti-PD-1 therapy is reduced in patients with cancer during COVID-19 vaccination. A large multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Qi, Hu, Guangyuan, Yang, Yang, Liu, Bo, Yin, Junping, Li, Ming, Huang, Qiao, Tang, Xi, Böhner, Alexander, Bryant, Amy, Kurts, Christian, Yuan, Xianglin, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915379/
https://www.ncbi.nlm.nih.gov/pubmed/35264438
http://dx.doi.org/10.1136/jitc-2021-004157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915379/
https://www.ncbi.nlm.nih.gov/pubmed/35264438
http://dx.doi.org/10.1136/jitc-2021-004157

Ejemplares similares